MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eide, E. J.
Right arrow Articles by Virshup, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eide, E. J.
Right arrow Articles by Virshup, D. M.
Molecular and Cellular Biology, April 2005, p. 2795-2807, Vol. 25, No. 7
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.7.2795-2807.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Control of Mammalian Circadian Rhythm by CKI{varepsilon}-Regulated Proteasome-Mediated PER2 Degradation

Erik J. Eide,1 Margaret F. Woolf,1 Heeseog Kang,1 Peter Woolf,2 William Hurst,3 Fernando Camacho,3 Erica L. Vielhaber,3 Andrew Giovanni,3 and David M. Virshup1,4*

Department of Oncological Sciences and the Center for Children, Huntsman Cancer Institute,1 Division of Hematology/Oncology, Department of Pediatrics, University of Utah, Salt Lake City, Utah,4 Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan,2 Aventis Pharmaceuticals, Bridgewater, New Jersey3

Received 1 October 2004/ Returned for modification 15 November 2004/ Accepted 28 December 2004

The mammalian circadian regulatory proteins PER1 and PER2 undergo a daily cycle of accumulation followed by phosphorylation and degradation. Although phosphorylation-regulated proteolysis of these inhibitors is postulated to be essential for the function of the clock, inhibition of this process has not yet been shown to alter mammalian circadian rhythm. We have developed a cell-based model of PER2 degradation. Murine PER2 (mPER2) hyperphosphorylation induced by the cell-permeable protein phosphatase inhibitor calyculin A is rapidly followed by ubiquitination and degradation by the 26S proteasome. Proteasome-mediated degradation is critically important in the circadian clock, as proteasome inhibitors cause a significant lengthening of the circadian period in Rat-1 cells. CKI{varepsilon} (casein kinase I{varepsilon}) has been postulated to prime PER2 for degradation. Supporting this idea, CKI{varepsilon} inhibition also causes a significant lengthening of circadian period in synchronized Rat-1 cells. CKI{varepsilon} inhibition also slows the degradation of PER2 in cells. CKI{varepsilon}-mediated phosphorylation of PER2 recruits the ubiquitin ligase adapter protein ß-TrCP to a specific site, and dominant negative ß-TrCP blocks phosphorylation-dependent degradation of mPER2. These results provide a biochemical mechanism and functional relevance for the observed phosphorylation-degradation cycle of mammalian PER2. Cell culture-based biochemical assays combined with measurement of cell-based rhythm complement genetic studies to elucidate basic mechanisms controlling the mammalian clock.


* Corresponding author. Mailing address: Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112. Phone: (801) 585-3408. Fax: (801) 587-9416. E-mail: david.virshup{at}hci.utah.edu.


Molecular and Cellular Biology, April 2005, p. 2795-2807, Vol. 25, No. 7
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.7.2795-2807.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2005 by the American Society for Microbiology. All rights reserved.